feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Abhay Deol's Stem Cell Journey for Pain Relief

Abhay Deol's Stem Cell Journey for Pain Relief

24 Jan

•

Summary

  • Actor Abhay Deol shared his positive stem cell therapy experience for knee pain and sciatica.
  • Stem cells can renew themselves and differentiate into various specialized cell types.
  • Unapproved stem cell therapies carry significant risks and lack proven efficacy, warns FDA.
Abhay Deol's Stem Cell Journey for Pain Relief

Stem cell therapy is gaining attention as a regenerative medicine approach for chronic pain conditions like joint and back issues, offering an alternative to surgery.

Actor Abhay Deol recently shared his personal journey, detailing how he underwent stem cell therapy in Korea to alleviate knee pain and sciatica stemming from a slip disc, avoiding surgery.

Stem cells are pivotal for tissue maintenance and repair, capable of self-renewal and transforming into various specialized cells like heart or nerve cells.

trending

Toyota recalls Tundra vehicles

trending

Bear spray attacks Houston stores

trending

Baltimore snowstorm causes closures

trending

Cincinnati winter storm warning issued

trending

NYC winter storm watch

trending

Indians choose ePassports increasingly

trending

Walmart Kroger winter storm updates

trending

Osaka withdraws from Australian Open

trending

José Ramírez gets extension

This therapy, also known as regenerative medicine, utilizes stem cells to repair damaged tissues and has shown promise in managing pain from conditions like osteoarthritis and discogenic back pain.

However, experts urge caution, noting that many private clinics offer unproven stem cell treatments lacking FDA approval and large-scale clinical trials.

Risks associated with unapproved therapies can be severe, including serious illness and blindness, alongside substantial financial burdens as they are rarely covered by insurance.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Abhay Deol used stem cell therapy to help alleviate knee pain and sciatica he experienced due to a slip disc.
Stem cells are special cells that can renew themselves and differentiate into other specialized cell types, aiding in tissue maintenance and repair.
Unapproved stem cell therapies can carry significant risks, including severe illness, blindness, and substantial financial costs, with no guarantee of effectiveness.

Read more news on

Healthside-arrow

You may also like

Regeneron Eyes Weight Loss Market, FDA Hearing Looms

14 Jan • 55 reads

article image

Indian Knees in Crisis: PRP & Stem Cells Under Scrutiny

14 Jan • 1 read

article image

Day-Care Bone Marrow Transplants Slash Costs

23 Dec, 2025 • 153 reads

article image

HRT: No Link to Dementia, Says New Study

23 Dec, 2025 • 145 reads

article image

Cancer Patients Fund Own Chemo Amid NHS Wait Woes

21 Dec, 2025 • 182 reads

article image